NMBio MemberVisionQuest Biomedical LLC

VisionQuest delivers innovative artificial intelligence–based imaging technologies that increase access to equitable, efficient, and cost-effective health care. Peter Soliz (PhD) founded the company in 2007 to advance AI techniques that would assist health-care professionals in evaluating digital medical photographs of diabetic retinopathy. VisionQuest is now applying retinal screening to the detection of malarial retinopathy in the sub-Saharan countries of Malawi, Kenya, and Nigeria. The company is also developing tools for the early detection of diabetic peripheral neuropathy (diabetic foot).